CURE Quest Award

Quest Award
Online LOI form		Submission Guidelines

CURE seeks novel research projects that will address the goals of “no seizures/no side effects.” This program awards seed grants to researchers submitting innovative proposals that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature.

Eligibility: This award is available to both established and early career investigators*. International applicants are welcome.

*Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization), and are within seven years of completion of graduate, professional, or research/clinical fellowship training. In exceptional cases, scientists at the postdoctoral level may be eligible for this award.

Amount: Requests may be made up to $50,000 a year. CURE gives priority to requests of one year. Applicants may request funding for two years; CURE will make determination based on scientific merit and availability of funding. Funding may not exceed a total of $100,000 for two years ($50,000 per year). Receipt of the second year of funding is contingent upon a successful review of the first year of work.

FUNDING CYCLE
Deadline for Receipt of LOI: November 15, 2006
Notification of Invitation to Apply: Mid-December 2006
Deadline for Receipt of Full Application: February 16, 2007
Award Announcement: May 2007
Earliest Project Start Date: July 1, 2007

Letter of Intent: All applicants must submit a Letter of Intent. If the research proposed in the LOI meets CURE’s funding priorities in a given year, the investigator will be invited to submit a formal proposal. All LOIs are reviewed by CURE’s Scientific Advisory Board and Research Review Board, with the final decision for application invitation made by the CURE Board of Directors.
**LOI SUBMISSION PHASE IS NOW CLOSED**

For questions, please contact the CURE office, 312.255-1801, or email admin@CUREepilepsy.org.

For full application and submission guidelines, click here.